Medtronic FX Effect on Cash decreased by 76.3% to $67.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 116.1%, from $31.00M to $67.00M. Over 2 years (FY 2021 to FY 2025), FX Effect on Cash shows a downward trend with a -9.7% CAGR.
Significant values indicate high exposure to international markets and currency volatility, requiring effective hedging strategies.
The impact of fluctuations in foreign currency exchange rates on the company's cash and cash equivalent balances held in...
Standard for multinational corporations; peers with similar geographic footprints will show similar sensitivity.
fx_effect| Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$42.00M | -$181.00M | -$144.00M | -$122.00M | -$92.00M | $531.00M | -$39.00M | $74.00M | -$205.00M | -$60.00M | $31.00M | $0.00 | -$123.00M | $283.00M | $67.00M |
| QoQ Change | — | — | -331.0% | +20.4% | +15.3% | +24.6% | +677.2% | -107.3% | +289.7% | -377.0% | +70.7% | +151.7% | -100.0% | — | +330.1% | -76.3% |
| YoY Change | — | — | — | — | -190.5% | +49.2% | — | +68.0% | +180.4% | -138.6% | — | +179.5% | -100.0% | +40.0% | +571.7% | +116.1% |